Evolus (EOLS) News Today $12.63 +0.24 (+1.94%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Evolus’ Resilience and Growth Potential Amid Market Challenges: A Buy Recommendation by Uy EarNovember 20 at 7:31 AM | markets.businessinsider.comEvolus, Inc. (NASDAQ:EOLS) Short Interest Up 8.8% in OctoberEvolus, Inc. (NASDAQ:EOLS - Get Free Report) saw a significant increase in short interest in the month of October. As of October 31st, there was short interest totalling 5,430,000 shares, an increase of 8.8% from the October 15th total of 4,990,000 shares. Based on an average daily volume of 613,400 shares, the short-interest ratio is currently 8.9 days.November 18 at 12:54 AM | marketbeat.comGSA Capital Partners LLP Buys 93,176 Shares of Evolus, Inc. (NASDAQ:EOLS)GSA Capital Partners LLP grew its stake in shares of Evolus, Inc. (NASDAQ:EOLS - Free Report) by 335.3% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 120,964 shares of the company's stock after purchasingNovember 13, 2024 | marketbeat.comEarnings Update: Evolus, Inc. (NASDAQ:EOLS) Just Reported Its Third-Quarter Results And Analysts Are Updating Their ForecastsNovember 9, 2024 | finance.yahoo.comEvolus, Inc. (NASDAQ:EOLS) Q3 2024 Earnings Call TranscriptNovember 8, 2024 | msn.comEvolus Inc (EOLS) Q3 2024 Earnings Call Highlights: Revenue Surge Amid Market ChallengesNovember 7, 2024 | finance.yahoo.comEvolus Maintains Strong Growth Outlook Despite Earnings Miss: A Buy RecommendationNovember 7, 2024 | markets.businessinsider.comStifel Nicolaus Sticks to Its Buy Rating for Evolus (EOLS)November 7, 2024 | markets.businessinsider.comEvolus (NASDAQ:EOLS) Shares Gap Down on Disappointing EarningsEvolus (NASDAQ:EOLS) Shares Gap Down Following Weak EarningsNovember 7, 2024 | marketbeat.comHC Wainwright Reiterates Buy Rating for Evolus (NASDAQ:EOLS)HC Wainwright reissued a "buy" rating and issued a $27.00 price target on shares of Evolus in a research report on Thursday.November 7, 2024 | marketbeat.comEvolus, Inc. (EOLS) Q3 2024 Earnings Conference Call TranscriptNovember 6, 2024 | seekingalpha.comEvolus Reports Third Quarter 2024 ResultsNovember 6, 2024 | businesswire.comEvolus Gets EU Approval for Treatment of WrinklesNovember 2, 2024 | marketwatch.comEvolus (NASDAQ:EOLS) Earns Buy Rating from HC WainwrightHC Wainwright reaffirmed a "buy" rating and set a $27.00 price target on shares of Evolus in a research report on Friday.November 1, 2024 | marketbeat.comEvolus to Participate in Stifel 2024 Healthcare ConferenceNovember 1, 2024 | businesswire.comEvolus, Inc. (NASDAQ:EOLS) Shares Acquired by Rice Hall James & Associates LLCRice Hall James & Associates LLC boosted its stake in Evolus, Inc. (NASDAQ:EOLS - Free Report) by 6.3% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 904,900 shares of the company's stock after acquiring an additional 53,605 shares during the quarter.November 1, 2024 | marketbeat.comEvolus Rewards(TM) Patient Loyalty Program Surpasses 1 Million Enrolled ConsumersOctober 31, 2024 | stockhouse.comEvolus Announces EU Approval of Estyme® Injectable Hyaluronic Acid Gels Under New Medical Device RegulationOctober 31, 2024 | businesswire.comEvolus (EOLS) to Release Earnings on WednesdayEvolus (NASDAQ:EOLS) will be releasing earnings after the market closes on Wednesday, November 6, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=638774)October 30, 2024 | marketbeat.comEvolus rewards patient loyalty program surpasses 1M enrolled consumersOctober 30, 2024 | markets.businessinsider.comEvolus Rewards™ Patient Loyalty Program Surpasses 1 Million Enrolled ConsumersOctober 29, 2024 | finance.yahoo.comSemanteon Capital Management LP Makes New $912,000 Investment in Evolus, Inc. (NASDAQ:EOLS)Semanteon Capital Management LP acquired a new stake in Evolus, Inc. (NASDAQ:EOLS - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 56,313 shares of the company's stock, valued at approOctober 28, 2024 | marketbeat.comEvolus (NASDAQ:EOLS) Shares Down 6.2% - Here's WhyEvolus (NASDAQ:EOLS) Trading Down 6.2% - What's Next?October 17, 2024 | marketbeat.comSG Americas Securities LLC Buys Shares of 38,447 Evolus, Inc. (NASDAQ:EOLS)SG Americas Securities LLC bought a new stake in shares of Evolus, Inc. (NASDAQ:EOLS - Free Report) during the third quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 38,447 shares of the company's stock, valued at approximately $623,000. SOctober 15, 2024 | marketbeat.comEvolus (NASDAQ:EOLS) Hits New 1-Year High - Time to Buy?Evolus (NASDAQ:EOLS) Reaches New 52-Week High - Here's WhyOctober 14, 2024 | marketbeat.comEvolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)October 11, 2024 | businesswire.comEvolus' (NASDAQ:EOLS) investors will be pleased with their solid 119% return over the last three yearsOctober 11, 2024 | finance.yahoo.comEvolus Inc (EOLS) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic AdvancementsOctober 9, 2024 | finance.yahoo.comEvolus, Inc. (NASDAQ:EOLS) Shares Sold by Millennium Management LLCMillennium Management LLC decreased its holdings in Evolus, Inc. (NASDAQ:EOLS - Free Report) by 4.0% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 899,377 shares of the company's stock after selling 36,996 shares during the quarter. MillOctober 9, 2024 | marketbeat.comHealthcare of Ontario Pension Plan Trust Fund Buys Shares of 122,200 Evolus, Inc. (NASDAQ:EOLS)Healthcare of Ontario Pension Plan Trust Fund bought a new stake in shares of Evolus, Inc. (NASDAQ:EOLS - Free Report) during the second quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 122,200 shares of the company's stock, valued at apprOctober 8, 2024 | marketbeat.comEvolus, Inc. to Post Q3 2024 Earnings of ($0.12) Per Share, HC Wainwright Forecasts (NASDAQ:EOLS)Evolus, Inc. (NASDAQ:EOLS - Free Report) - Equities research analysts at HC Wainwright lowered their Q3 2024 earnings estimates for Evolus in a report released on Thursday, October 3rd. HC Wainwright analyst D. Tsao now expects that the company will post earnings per share of ($0.12) for the quarOctober 7, 2024 | marketbeat.comEvolus (NASDAQ:EOLS) Stock Quotes, Forecast and News SummaryOctober 6, 2024 | benzinga.comEvolus (NASDAQ:EOLS) Trading Down 3.4% - Here's WhyEvolus (NASDAQ:EOLS) Trading Down 3.4% - Here's WhyOctober 4, 2024 | marketbeat.comBrokers Issue Forecasts for Evolus, Inc.'s Q4 2024 Earnings (NASDAQ:EOLS)Evolus, Inc. (NASDAQ:EOLS - Free Report) - Stock analysts at HC Wainwright upped their Q4 2024 earnings per share (EPS) estimates for Evolus in a report issued on Thursday, October 3rd. HC Wainwright analyst D. Tsao now expects that the company will earn $0.01 per share for the quarter, up from tOctober 4, 2024 | marketbeat.comEvolus Poised for Robust Growth with Market Share Gains and Innovative ‘Cold Technology’ FillersOctober 4, 2024 | markets.businessinsider.comA Closer Look at 5 Analyst Recommendations For EvolusOctober 4, 2024 | benzinga.comHC Wainwright Reaffirms Buy Rating for Evolus (NASDAQ:EOLS)HC Wainwright restated a "buy" rating and issued a $27.00 price target on shares of Evolus in a report on Thursday.October 3, 2024 | marketbeat.comStonepine Capital Management LLC Sells 1,016,745 Shares of Evolus, Inc. (NASDAQ:EOLS)Stonepine Capital Management LLC decreased its position in Evolus, Inc. (NASDAQ:EOLS - Free Report) by 38.0% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,657,611 shares of the company's stock after seOctober 1, 2024 | marketbeat.comEvolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)September 27, 2024 | businesswire.comArmistice Capital LLC Takes Position in Evolus, Inc. (NASDAQ:EOLS)Armistice Capital LLC purchased a new position in Evolus, Inc. (NASDAQ:EOLS - Free Report) during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm purchased 360,000 shares of the company's stock, valued at approximately $3,906,000. Armistice Capital LLC owned about 0.September 27, 2024 | marketbeat.comEvolus Inc (EVL.DU)September 23, 2024 | nz.finance.yahoo.comBank of New York Mellon Corp Acquires 35,760 Shares of Evolus, Inc. (NASDAQ:EOLS)Bank of New York Mellon Corp lifted its holdings in Evolus, Inc. (NASDAQ:EOLS - Free Report) by 24.6% in the second quarter, according to the company in its most recent filing with the SEC. The fund owned 181,093 shares of the company's stock after acquiring an additional 35,760 shares during the qSeptember 18, 2024 | marketbeat.comEvolus’s Strategic Growth and Market Expansion Garner a Buy RatingSeptember 16, 2024 | markets.businessinsider.comEvolus (NASDAQ:EOLS) Stock Rating Reaffirmed by Cantor FitzgeraldCantor Fitzgerald reaffirmed an "overweight" rating on shares of Evolus in a report on Monday.September 16, 2024 | marketbeat.com3 Best Stocks to Buy Now, 9/13/2024, According to Top AnalystsSeptember 15, 2024 | msn.comEvolus Buy Rating Justified by Strong Market Positioning and Growth ProjectionsSeptember 14, 2024 | markets.businessinsider.comStifel Nicolaus Reaffirms Their Buy Rating on Evolus (EOLS)September 14, 2024 | markets.businessinsider.comEvolus Rings the Closing BellSeptember 13, 2024 | nasdaq.comAnalyst Scoreboard: 4 Ratings For EvolusSeptember 13, 2024 | benzinga.comBarclays Raises Evolus (NASDAQ:EOLS) Price Target to $20.00Barclays upped their price target on shares of Evolus from $16.00 to $20.00 and gave the company an "overweight" rating in a research note on Friday.September 13, 2024 | marketbeat.com Get Evolus News Delivered to You Automatically Sign up to receive the latest news and ratings for EOLS and its competitors with MarketBeat's FREE daily newsletter. Email Address When it comes to NVDA… “acceleration cycles” are the key (Ad)Expert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again. Use this link to see Nvidia Unchained right away! EOLS Media Mentions By Week EOLS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EOLS News Sentiment▼1.320.46▲Average Medical News Sentiment EOLS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EOLS Articles This Week▼24▲EOLS Articles Average Week Get Evolus News Delivered to You Automatically Sign up to receive the latest news and ratings for EOLS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Agios Pharmaceuticals News Today Verona Pharma News Today PTC Therapeutics News Today Dyne Therapeutics News Today Bausch Health Companies News Today Edgewise Therapeutics News Today Merus News Today Xenon Pharmaceuticals News Today HUTCHMED News Today Vera Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EOLS) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredTesla Execs are Freaking OutIt’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands...Angel Publishing | SponsoredJD Vance Predicts: Wall Street vs. Trump & Your MoneyTrump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purpose...Priority Gold | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredTrump said you could learn something from this manEarly Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide vic...Wide Moat Research | SponsoredThis Bull Market Indicator called NVDA at $116Every now and again we find an investment idea so incredible we can’t help but share. And today is one of ...WealthPress | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evolus, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evolus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
